Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Gyre Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 21 | 30 | +9 |
| Shares | 816.8K | 1.26M | +440.9K (+54.0%) |
| Value | $14.3M | $15.0M | +$734.0K (+5.1%) |
New holders (16)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Charles Schwab Investment Management Inc | 23,091 | $275.5K | 0.00% |
| Winton Group Ltd | 18,467 | $220.3K | 0.01% |
| Bank of New York Mellon Corp | 18,266 | $217.9K | 0.00% |
| Renaissance Technologies LLC | 13,900 | $165.8K | 0.00% |
| Rhumbline Advisers | 10,291 | $122.8K | 0.00% |
| New York State Common Retirement Fund | 10,200 | $121.7K | 0.00% |
| Bank of America Corp | 4,969 | $59.3K | 0.00% |
| Corebridge Financial, Inc. | 3,752 | $44.8K | 0.00% |
| Barclays PLC | 2,433 | $29.0K | 0.00% |
| UBS Group AG | 2,123 | $25.3K | 0.00% |
| Royal Bank of Canada | 1,052 | $13.0K | 0.00% |
| Ameritas Investment Partners, Inc. | 683 | $8.15K | 0.00% |
| Legal & General Group Plc | 603 | $7.13K | 0.00% |
| Activest Wealth Management | 533 | $6.36K | 0.00% |
| California State Teachers Retirement System | 505 | $6.03K | 0.00% |
| Amalgamated Bank | 241 | $3.00K | 0.00% |
Sold out (7)
Institutions that held Gyre Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Millennium Management LLC | 60,319 | $1.05M |
| Goldman Sachs Group Inc | 46,093 | $805.7K |
| Jane Street Group, LLC | 30,555 | $534.1K |
| Balyasny Asset Management LLC | 13,979 | $244.4K |
| Qube Research & Technologies Ltd | 6,235 | $109.0K |
| Old Point Trust & Financial Services N A | 33 | $577 |
| Macquarie Group Ltd | 408 | $7 |